Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit I Giasson

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
Acta Neuropathologica|May 12, 2021
Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potentialNelson Ferreira, Hjalte Gram, Zachary A Sorrentino, et al.
The Journal of Experimental Medicine|August 31, 2019
An anti-CRF antibody suppresses the HPA axis and reverses stress-induced phenotypesHunter S Futch, Karen N McFarland, Brenda D Moore, et al.
The Journal of Experimental Medicine|August 31, 2018
TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's diseaseParamita Chakrabarty, Andrew Li, Thomas B Ladd, et al.
JAMA Neurology|April 17, 2013
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodiesMichael A Nalls, Raquel Duran, Grisel Lopez, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
Acta Neuropathologica|May 12, 2021
Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potentialNelson Ferreira, Hjalte Gram, Zachary A Sorrentino, et al.
The Journal of Experimental Medicine|August 31, 2019
An anti-CRF antibody suppresses the HPA axis and reverses stress-induced phenotypesHunter S Futch, Karen N McFarland, Brenda D Moore, et al.
The Journal of Experimental Medicine|August 31, 2018
TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's diseaseParamita Chakrabarty, Andrew Li, Thomas B Ladd, et al.
JAMA Neurology|April 17, 2013
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodiesMichael A Nalls, Raquel Duran, Grisel Lopez, et al.
Pageof 18